Streetbeat News

Products Services

ASTR

COIN

GAN

LLY

MARA

Benzinga's Stock Whisper Index highlights five stocks: GAN Limited after an acquisition announcement by Sega Sammy Creation; Marathon Digital Holdings following Q3 results and Bitcoin production increase; Eli Lilly with FDA approval for Tirzepatide; Astra Space after a buyout proposal from its founders; and Coinbase Global due to Q3 revenue beat and Bitcoin optimism. These stocks are gaining investor interest and could see short-term impacts.

Portfolio Pulse from Chris Katje

November 10, 2023 | 3:45 pm

ABNB

VGK

EU countries and lawmakers are expected to reach an agreement on regulations for short-term rental services like Airbnb next week. The rules are anticipated to be 'light touch,' suggesting a less stringent regulatory environment for the industry.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 3:44 pm

BLK

Wall Street firms are increasingly focusing on tokenizing assets on the blockchain, with State Street Global Advisors expressing interest in tokenizing ETFs and BlackRock's CEO Larry Fink acknowledging the operational potential of blockchain technologies. Citigroup has initiated a pilot called 'Citi Token Services' for institutional clients. Analysts predict the asset tokenization market could reach $10 trillion by 2030, a significant increase from the current $300 billion.

Portfolio Pulse from Tanzeel Akhtar

November 10, 2023 | 3:37 pm

TSN

Tyson Foods, Inc. (NYSE:TSN) is expected to report lower earnings for Q4 2023, with analysts predicting earnings of $0.29 per share compared to $1.63 per share a year ago. Revenue is anticipated to be slightly down at $13.73 billion versus $13.74 billion. The company has also initiated a recall of about 29,819 pounds of chicken products due to contamination concerns. Shares closed up slightly at $46.40. Analysts from BMO Capital, Goldman Sachs, Barclays, JP Morgan, and Piper Sandler have provided various ratings and price targets for Tyson Foods.

Portfolio Pulse from Lisa Levin

November 10, 2023 | 3:33 pm

BBY

BIG

COST

DLTR

TGT

XRT

Big Lots Inc (NYSE:BIG) experienced a significant stock price drop of 10.69% on Nov. 9, reaching all-time lows of $3.68 with high trading volume. Despite being undervalued compared to peers like Dollar Tree, Dollar General, Best Buy, Target, and Costco, Goldman Sachs maintains a Sell rating with a lowered price target of $4. The retail sector, including the SPDR S&P Retail ETF (NYSE:XRT), has been negatively impacted by inflation. However, Big Lots is attempting to improve profitability through product refreshes, promotional deals, and cost reductions. Upcoming Q3 earnings on Nov. 30 will provide further insight into whether this is a buy-the-dip opportunity.

Portfolio Pulse from Surbhi Jain

November 10, 2023 | 3:30 pm

TSLA

A biopic about Elon Musk, based on a biography by Walter Isaacson, is being developed by A24 with Darren Aronofsky set to direct. The film will explore Musk's life, including his roles at Tesla Inc, SpaceX, and the acquisition of Twitter. No casting or release date details are available yet. The biopic's impact on Musk's past work, including the 'Steve Jobs' biopic, suggests potential interest in the upcoming film.

Portfolio Pulse from Chris Katje

November 10, 2023 | 3:27 pm

AMZN

GOOG

GOOGL

Amazon is developing its own operating system, Vega, to replace Android on its devices, aiming for a 2024 release. The OS will reduce reliance on Android Open Source Project and allow for a broader range of app development. Amazon's move is strategic to gain control over its technology and expand monetization opportunities. AMZN shares saw a slight increase of 0.48% to $141.37.

Portfolio Pulse from Anusuya Lahiri

November 10, 2023 | 2:51 pm

ALVO

STADA and Alvotech have received a positive CHMP opinion for Europe's first biosimilar to Stelara, Uzpruvo (AVT04), for use in gastroenterology, dermatology, and rheumatology. This marks the first EMA proposal for a biosimilar to Stelara, with potential market entry into the €2.5 billion EU ustekinumab market. STADA holds commercial rights in Europe, while Alvotech is responsible for development and manufacturing. The biosimilar could significantly expand patient access and provide cost-effective treatment options in the EU.

Portfolio Pulse from Benzinga Newsdesk

November 10, 2023 | 2:30 pm

EAT

Brinker International (NYSE:EAT), owner of Chili's Grill & Bar, reported a 5.8% increase in comparable sales year-over-year for Q1, with revenue of $1.012 billion. Chili's, known for its margaritas, would rank as the third-largest buyer of tequila if it were a country. The company's focus on 'core four' items, including margaritas, is part of its strategy to return to the basics of casual dining. Brinker projects FY2024 revenue of $4.27 to $4.35 billion and EPS of $3.35 to $3.65.

Portfolio Pulse from Chris Katje

November 10, 2023 | 2:23 pm

AAPL

NVDA

TSM

Taiwan Semiconductor Manufacturing Co (TSM) reported a significant month-on-month topline growth of 34.8% in October, with the strong dollar and Apple Inc's new product launch contributing to this growth. TSMC is also planning to build its second wafer fab in Japan, focusing on 6nm process manufacturing, with substantial financial commitment from the Japanese government. Nvidia Corp's CEO praised TSMC for its role in Nvidia's success at a recent event in Taipei.

Portfolio Pulse from Anusuya Lahiri

November 10, 2023 | 2:13 pm